scholarly journals Phase I study of TZT-1027, a novel synthetic dolastatin 10 derivative and inhibitor of tubulin polymerization, given weekly to advanced solid tumor patients for 3 weeks

2009 ◽  
Vol 100 (2) ◽  
pp. 316-321 ◽  
Author(s):  
Nobuyuki Yamamoto ◽  
Masahiro Andoh ◽  
Masaaki Kawahara ◽  
Masahiro Fukuoka ◽  
Hisanobu Niitani
Keyword(s):  
Phase I ◽  
Solid Tumor ◽  
Phase I Study ◽  
Tubulin Polymerization ◽  
Advanced Solid Tumor ◽  
Tumor Patients ◽  
Dolastatin 10

scholarly journals Phase I study of nanoliposomal irinotecan (PEP02) in advanced solid tumor patients

2015 ◽  
Vol 75 (3) ◽  
pp. 579-586 ◽  
Author(s):  
T. C. Chang ◽  
H. S. Shiah ◽  
C. H. Yang ◽  
K. H. Yeh ◽  
A. L. Cheng ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumor ◽  
Phase I Study ◽  
Advanced Solid Tumor ◽  
Tumor Patients ◽  
Nanoliposomal Irinotecan

A phase I study of pemetrexed in combination with docetaxel in advanced solid tumor patients.

2014 ◽  
Vol 32 (15_suppl) ◽  
pp. 2567-2567
Author(s):  
Lee D. Cranmer ◽  
Sherif S. Morgan ◽  
Amy S Bauland ◽  
Yrma Burruel ◽  
Jeanette S Cardenas ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumor ◽  
Phase I Study ◽  
Advanced Solid Tumor ◽  
Tumor Patients

Phase I study of liposome encapsulated irinotecan (PEP02) in advanced solid tumor patients

2008 ◽  
Vol 26 (15_suppl) ◽  
pp. 2565-2565 ◽  
Author(s):  
L. Chen ◽  
T. Chang ◽  
A. Cheng ◽  
C. Yang ◽  
H. Shiah ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumor ◽  
Phase I Study ◽  
Advanced Solid Tumor ◽  
Tumor Patients

A phase I study of intravenous artesunate in patients with advanced solid tumor malignancies

2018 ◽  
Vol 81 (3) ◽  
pp. 587-596 ◽  
Author(s):  
John F. Deeken ◽  
Hongkun Wang ◽  
Marion Hartley ◽  
Amrita K. Cheema ◽  
Brandon Smaglo ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumor ◽  
Phase I Study ◽  
Advanced Solid Tumor

scholarly journals A phase I study of liposomal-encapsulated docetaxel (LE-DT) in patients with advanced solid tumor malignancies

2012 ◽  
Vol 71 (3) ◽  
pp. 627-633 ◽  
Author(s):  
John F. Deeken ◽  
Rebecca Slack ◽  
Glen J. Weiss ◽  
Ramesh K. Ramanathan ◽  
Michael J. Pishvaian ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumor ◽  
Phase I Study ◽  
Advanced Solid Tumor

A phase I study of the CDK4/6 inhibitor, palbociclib plus 5-fluorouracil (5FU) in patients with advanced solid tumor malignancies (NCT01522989).

2016 ◽  
Vol 34 (15_suppl) ◽  
pp. 2589-2589 ◽  
Author(s):  
Michael J. Pishvaian ◽  
Hongkun Wang ◽  
Brandon George Smaglo ◽  
Jennifer Gao ◽  
Laura Macke ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumor ◽  
Phase I Study ◽  
Advanced Solid Tumor
Sign in / Sign up

Export Citation Format

Share Document